home All News open_in_new Full Article

Un fármaco para frenar el Alzheimer es bien tolerado fuera de los ensayos clínicos

MADRID 12 May. (EUROPA PRESS) – Un nuevo estudio revela que los efectos secundarios del lecanemab son manejables, según investigadores de la… The post Un fármaco para frenar el Alzheimer es bien tolerado fuera de los ensayos clínicos appeared first on Caretas.


today 3 w. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Society
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events


ID: 3668322121
Add Watch Country

arrow_drop_down